Sunday, July 06, 2025 9:22:13 PM
For anyone who lacks basic English language knowledge when writing an email, let me explain to you why this "email" is fake and just another scare tactic.
1. No period? "Any correspondence should be addressed to the company as previously indicated"
2. No last name? Who responds to an email just their first name? Especially from an MHRA rep?
3. Communications and engagement team. Engagement should be capitalized.
4. No date, email address info or anything. I could make something like this in Microsoft Word in 2 minutes. I expect an email from a customer service rep of a government agency would be a little more professional than this bs.
5. Pretty convenient how the first thing this clown says is that the company must be in an RFI. "ITs ThE OnLy ExPlANatIon!" Wonder where we've heard that before?
I've put a great number of clowns on ignore this week as it feels like they are climbing out of the circus tents in masses as of late, trying to spread last minute fear. I'm not sure when we will get news of approval. I'm not one to make baseless predictions. I just know that when approval is announced, shorts won't know what hit them.
1. No period? "Any correspondence should be addressed to the company as previously indicated"
2. No last name? Who responds to an email just their first name? Especially from an MHRA rep?
3. Communications and engagement team. Engagement should be capitalized.
4. No date, email address info or anything. I could make something like this in Microsoft Word in 2 minutes. I expect an email from a customer service rep of a government agency would be a little more professional than this bs.
5. Pretty convenient how the first thing this clown says is that the company must be in an RFI. "ITs ThE OnLy ExPlANatIon!" Wonder where we've heard that before?
I've put a great number of clowns on ignore this week as it feels like they are climbing out of the circus tents in masses as of late, trying to spread last minute fear. I'm not sure when we will get news of approval. I'm not one to make baseless predictions. I just know that when approval is announced, shorts won't know what hit them.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
